These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2430652)

  • 21. Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord.
    Gonzalez-Barcena D; Vadillo-Buenfil M; Cortez-Morales A; Fuentes-Garcia M; Cardenas-Cornejo I; Comaru-Schally AM; Schally AV
    Urology; 1995 Feb; 45(2):275-81. PubMed ID: 7531902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of advanced prostatic cancer with a gonadorelin agonist, dTrp6 LHRH. 41 cases].
    Steg A; Chiche R; Boccon-Gibod L; Debré B
    Presse Med; 1985 Nov; 14(40):2045-8. PubMed ID: 2934695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure to maintain a suppressed level of serum testosterone during long-acting depot luteinizing hormone-releasing hormone agonist therapy in patients with advanced prostate cancer.
    Morote J; Esquena S; Abascal JM; Trilla E; Cecchini L; Raventós CX; Catalán R; Reventós J
    Urol Int; 2006; 77(2):135-8. PubMed ID: 16888418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-Trp-6-LH-RH treatment of advanced prostatic cancer.
    Boccardo F; Giuliani L; Santi L
    Lancet; 1986 Mar; 1(8481):621. PubMed ID: 2869332
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contribution to studies on the treatment of cancer of the prostate with D-Trp6-LH-RH].
    Marcellino LR; Campanella A; Bandini M
    Biomed Pharmacother; 1987; 41(9-10):468-72. PubMed ID: 2968123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on prevention of flare-up phenomenon following initial LH-RH analogue administration: combination therapy with diethylstilbestrol].
    Takeuchi S; Yoshida K; Tosaka A; Kobayashi N; Higashi Y; Negishi T
    Hinyokika Kiyo; 1995 Mar; 41(3):191-6. PubMed ID: 7741071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
    Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
    Fuse H; Akimoto S; Akakura K; Shimazaki J; Murakami S
    Hinyokika Kiyo; 1988 Mar; 34(3):555-60. PubMed ID: 3133936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How would you like to have an orchidectomy for advanced prostatic cancer?
    Parmar H; Phillips RH; Lightman SL; Edwards L
    Am J Clin Oncol; 1988; 11 Suppl 2():S160-8. PubMed ID: 2977271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dynamic study of the hormonal levels and tumor markers after the first administration of long-acting LH-RH analogue in patients with prostate cancer].
    Takeuchi S; Yoshida K; Tosaka A; Kobayashi N; Uchijima Y; Saitoh H
    Hinyokika Kiyo; 1994 May; 40(5):393-400. PubMed ID: 7517620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Decapeptyl (D-Trp6-LH-RH) in the therapy of prostatic cancer with reference to the intramuscular administration of a depot preparation].
    Seppelt U; Bertermann H; Saerbeck C
    Urologe A; 1986 Sep; 25(5):298-301. PubMed ID: 2947371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.
    Chertin B; Spitz IM; Lindenberg T; Algur N; Zer T; Kuzma P; Young AJ; Catane R; Farkas A
    J Urol; 2000 Mar; 163(3):838-44. PubMed ID: 10687989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma.
    Parmar H; Phillips RH; Lightman SL; Edwards L; Allen L; Schally AV
    Lancet; 1985 Nov; 2(8466):1201-5. PubMed ID: 2866289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous phosphorylation in Dunning prostate tumors of rats treated with LH-RH analogues.
    Cehovic G; Redding TW; Hierowski MT; Schally AV
    Prostate; 1984; 5(6):605-11. PubMed ID: 6238290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
    Kaku H; Saika T; Tsushima T; Ebara S; Senoh T; Yamato T; Nasu Y; Kumon H
    Prostate; 2006 Mar; 66(4):439-44. PubMed ID: 16329145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR].
    Niijima T; Aso Y; Akaza H; Fujita K; Fuse H; Hosaka M; Isurugi K; Kamidono S; Katayama T; Kawabe K
    Hinyokika Kiyo; 1990 Nov; 36(11):1343-60. PubMed ID: 2126912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting agonists of LH-RH in the treatment of large ovarian endometriomas.
    Cortes-Prieto J; Lledo A; Avila C; Cortes-Garcia L; D'Acunto A; Luisi M; Comaru-Schally AM; Schally AV
    Int J Fertil; 1987; 32(4):290-7. PubMed ID: 2887526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preventive effect of chlormadinone acetate on flare-up phenomenon in advanced prostate cancer administered with a luteinizing hormone-releasing hormone analogue].
    Sato N; Kotake T; Masai M; Sakai S; Ito H
    Hinyokika Kiyo; 2000 Jan; 46(1):1-7. PubMed ID: 10723656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
    Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH2(10)]LH-RH ethylamide.
    Dupont A; Dupont P; Belanger A; Mailoux J; Cusan L; Labrie F
    Fertil Steril; 1990 Aug; 54(2):227-32. PubMed ID: 2199228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.